INTRODUCTION
============

The insulin-like growth factor (IGF) superfamily, is a functionally diverse protein family that mediates in the metabolism, growth, and differentiation of mammals. The family consists of two ligands (IGF1 and IGF2), two receptors (IGF1R and IGF2R), and six binding proteins (insulin-like growth factor binding protein \[IGFBP1 to IGFBP6\])([@b1-ajas-28-1-20]). The IGF1 is a small peptide hormone and responsible for mammalian metabolism, growth, and development ([@b1-ajas-28-1-20]). Furthermore, IGF-1 can induce the expression of hypoxia inducible factor (HIF1) under hypoxic or ischemic condition, triggering the expression of various target genes that regulate the cellular hypoxic response ([@b9-ajas-28-1-20]; [@b15-ajas-28-1-20]; [@b5-ajas-28-1-20]; [@b13-ajas-28-1-20]). The IGFBP-1, a key modulator protein of the IGF system, is mainly synthesized in hepatocytes and renal cells and released from the liver into the circulation to bind to IGF-1 with higher affinity than its receptor IGFR1 to govern IGF-1 bioavailability and action. Moreover, a growing body evidence has shown that IGFBP-1 plays an important role in hypoxic response through adjusting the availability of IGF1 in circulation, influencing its downstream reaction ([@b7-ajas-28-1-20]; [@b1-ajas-28-1-20]; [@b16-ajas-28-1-20]; [@b21-ajas-28-1-20]).

In recent years, the adaptation of plateau mammals to high-altitude hypoxia has attracted increasing attention. Numerous species on the Tibet plateau have been examined to explore the hypoxia-related molecular mechanisms ([@b18-ajas-28-1-20]; [@b3-ajas-28-1-20]; [@b2-ajas-28-1-20]; [@b22-ajas-28-1-20]), but little information about yaks is available. Yak (*Bos grunniens*) is the most important animal species in the Qinghai-Tibet plateau not only because of its economic value in meat, milk, and usage in agriculture, but also as an ideal model animal for studying the molecular mechanisms of adapting to the cold and low-oxygen environment ([@b6-ajas-28-1-20]). By contrast, closely related and cross-fertile cattle (*Bos taurus*) suffer from severe pulmonary hypertension when reared in the same habitat ([@b19-ajas-28-1-20]; [@b20-ajas-28-1-20]; [@b6-ajas-28-1-20]). Yaks have numerous anatomical and physiological traits that equip them for life at high altitude. Therefore, this highland animal is an ideal model animal for studying the mechanisms of adapting to cold and low-oxygen environments. In this study, we compared the variation in the nucleotide sequences and mRNA expression levels of IGF-1 and IGFBP-1 genes in the yak and lowland cattle to examine whether base mutations or expression levels of genes might be associated with the difference in adaptation to hypoxia.

MATERIALS AND METHODS
=====================

Sample collection and preservation
----------------------------------

The yaks were purchased from the Ganzi district (3500 m in altitude), Sichuan, China, and cattle were obtained from the Guanghan county (450 m in altitude). Several tissues from the heart, liver, spleen, lung, kidney, large intestine, small intestine, stomach, muscle, mammary gland, ovary, testis, and brain were collected through slaughter and were immediately frozen in liquid nitrogen until future use. All experimental procedures were performed according to Guidelines on the Care and Use of Laboratory Animals of the Institutional Animal Care and Use Committee of Southwest University for Nationalities, Sichuan, China.

RNA isolation and reverse transcription-polymerase chain reaction
-----------------------------------------------------------------

RNAs were isolated using Trizol (Invitrogen, Shanghai, China) according to the manufacturer's instructions. Reverse transcription was performed using an RT reagent kit (Takara, Dalian, China). The generated cDNA was amplified using gene specific primers (IGF1:5′-AATGGGAAAAATCAGCAGTCTT -3′/5′-TTCTGTAG TTCTTGTTTCCTGCA -3′; IGFBP1: 5′-TTCCTGTC TGCCACCCA -3′/5′-TTGCATCTGTTTTCAGTTCTG -3′) designed based on the conserved regions of corresponding cDNAs among sheep, goat, and cattle available in the GenBank database. The purified PCR products were cloned into PMD-19T vectors (Takara, China) and sequenced.

Bioinformatics analysis
-----------------------

The sequences of cloned genes were subjected to basic local alignment search tool analysis for verification. The identity of *IGF-1* and *IGFBP-1* gene between yak and other mammals were analyzed using online Multalin software.

Tissue expression patterns of *IGF-1* and *IGFBP-1* genes
---------------------------------------------------------

The expression patterns of *IGF-1* and *IGFBP-1* genes in the different tissues were investigated using semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) on cDNAs obtained from the different tissues, and the *β-actin* gene was chosen as the positive control. PCRs were performed using special primers (IGF: 5′-GTGCGGAGACAGGGGCTTT-3′/5′-ACTTGGCGGGC TTGAGAGG-3′; IGFBP1: 5′-CACTTGATGGCCGAGT CCA-3′/5′-CCTCCAGCGACGTCTCACA-3′; β-actin: 5′-AGGTGACAGCAGTCGGTTGGA-3′/5′\--CCTTAGAGA GAAGCGGGGTGG -3′).

Quantitative real-time polymerase chain reaction
------------------------------------------------

Considering that the IGF-1 and IGFBP-1 in the blood are predominately produced in the liver and kidney, the expression levels of IGF1 and IGFBP1 between the yak and cattle were compared. Moreover, *β-actin* gene was chosen to normalize the expression levels of the target genes. Real-time PCR was performed using a CFX-manger connect real-time detection system (Bio-Rad, Hercules, CA, USA) with SYBR Premix Ex-Taq TM II (Takara, China). All samples were ran in triplicate, and the gene expression level was calculated according to the 2^−ΔCt^ method ([@b14-ajas-28-1-20]). Statistical differences were analyzed using Student's *t*-test, and the variance was considered significant when p\<0.05.

RESULTS AND DISCUSSIONS
=======================

Molecular characterization of cDNAs for IGF-1 and IGFBP-1
---------------------------------------------------------

The cloned sequences of IGF-1 and IGFBP-1 were 468 and 792 bp, respectively, and sequences were submitted to the GenBank under Accession Nos. KJ489376 and KJ489377, respectively. The *IGF-1* gene was predicted to encode a peptide of 154 amino acid residues, including a signal peptide (49 residues), a mature peptide (70 residues), and a 35-residue C-terminal extension (E). Four characteristic domains of IGF-1 (B, C, A, and D) were also predicted in the mature peptide, based on its conservation among mammals ([Figure 1A](#f1-ajas-28-1-20){ref-type="fig"}). Compared with the other mammals, no special variation was detected in the IGF-1 mature peptide. The *IGFBP-1* gene encodes a peptide of 263 amino-acid residues, composed of N domain, central linker domain, and C domain ([Figure 1B](#f1-ajas-28-1-20){ref-type="fig"}). The N and C domains, which are rich in cysteine and responsible for IGF binding, were highly conserved in *B. grunniens*. Additionally, the arginine - glycine - aspartic acid motif in the C domain, which was verified to be involved in IGF-independent effect, was also examined in *B. grunniens*. Thus, *IGF-1* and *IGFBP-1* genes from *B. grunniens* shared high homology with those of *B. taurus*, *Ovis aries*, and *homo sapiens* in the nucleotide and protein level, which suggests that the base mutations of the two target genes do not induce the different resistances to hypoxia.

Tissue distribution analysis of IGF-1 and IGFBP-1
-------------------------------------------------

Semi-quantitative RT-PCR was performed to examine the distribution patterns of IGF-1 and IGFBP-1 in bovines. The IGF-1 and IGFBP-1 transcripts were detected in all tissues examined ([Figure 2](#f2-ajas-28-1-20){ref-type="fig"}). Higher levels of IGF-1 transcript were noted in the heart, liver, spleen, kidney, large intestine, stomach, muscle, and brain. Higher levels of IGFBP-1 transcript were detected in the liver, kidney, muscle, brain. These results are in accordance with the previous finding that the IGF-1 and IGFBP-1 are synthesized mainly in the liver and released into the circulation to regulate growth and development ([@b12-ajas-28-1-20]). In addition, the widespread distribution of IGF-1 and IGFBP-1 supported their varied physiological roles in animals.

Variation in the mRNA expression levels of IGF-1 and IGFBP-1 in Tibet plateau yaks and lowland cattle
-----------------------------------------------------------------------------------------------------

The IGF-1 is a hormone that regulates the growth of vertebrates and can protect cells against certain type of stress. The IGF-1 can improve the survival of cells under hypoxic or ischemic conditions ([@b10-ajas-28-1-20]; [@b4-ajas-28-1-20]). Studies have shown that IGF-1 in circulation can exert its biological effects through binding to and activating the transmembrane receptors ([@b11-ajas-28-1-20]). However, the availability of IGF-1 is regulated by IGFBPs, including IGFBP-1. Under the stimulus of low oxygen, IGFBP-1 expression can be upregulated; consequently, the availability of IGF-1 would be reduced, and IGFR pathway would be inhibited ([@b8-ajas-28-1-20]; [@b16-ajas-28-1-20]). However, little information is available on the variation in the expression patterns of IGF-1 and IGFBP-1 between plateau and lowland animals that may be used to investigate the molecular mechanisms adapting to hypoxia for highland animals.

Yaks of the Qinghai-Tibet plateau live at high altitudes from 3,000 m to 5,000 m and have been exposed generation by generation to the hypoxic and cold environment. In this study, we compared the difference in the expression levels of IGF-1 and IGFBP-1 in liver and kidney tissues between yaks and lowland cattle. Results showed that both IGF-1 and IGFBP-1 were highly expressed in the liver than in the kidney in the same species ([Figure 3](#f3-ajas-28-1-20){ref-type="fig"}), which is in agreement with the findings in previous reports ([@b12-ajas-28-1-20]; [@b22-ajas-28-1-20]). Comparison of the two breeds showed that the expression level of IGF-1 was higher (p\<0.05) in the tissues of yaks than that in cattle, indicating that IGF-1 may play an important role in the adaptation to the hypoxic environment. In the yak, the upregulated expression of IGF-1 can induce HIF1 expression, and hence, trigger various genes to express and regulate the cellular hypoxia response ([@b5-ajas-28-1-20]; [@b17-ajas-28-1-20]). In addition, *IGFBP-1* gene was expressed at a significantly higher level in the liver of cattle than that in yaks (p\<0.05), but it had similar expression levels in the kidneys of both species. The IGFBP-1 is mainly synthesized in the liver, and lesser production of IGFBP-1 can ensure sufficient IGF-1 in circulation to bind to the IGFR to respond to hypoxic stress in yak. Moreover, the equal IGFBP-1 in yak indicates that IGFBP-1 might have other different physiological roles in yak.

In summary, we have cloned and characterized the cDNA sequences of IGF-1 and IGFBP-1 from yaks. The widespread distribution of IGF-1 and IGFBP-1 suggested that they play important roles in the growth and development in bovines. Moreover, the upregulated IGF-1 expression and downregulated IGFBP-1 expression are associated with hypoxia adaptive response. In our future studies we will investigate the molecular mechanism of *IGF-1* and *IGFBP-1* gene regulation associated with the adaptation to hypoxia to elucidate the differential expression.
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![Alignment of deduced amino acid sequences of *IGF-1* and *IGFBP-1* genes. The peptide of (A) IGF-1 and (B) IGFBP-1 were compared with the corresponding sequences from *B. taurus*, *O. aries*, and *H. sapiens*. Conserved sequences are indicated by (●), and the variant residues were listed. The predicted domains of the IGF-1 (signal peptide, B domain, C domain, A domain, D domain, E domain) and IGFBP-1 (signal peptide, N domain, central linker domain, C domain) were also marked. The highly conserved cysteines in the IGFBP-1 were indicated by "\*", and the characteristic RGD motif in the C domain was indicated by "@". IGF-1, insulin-like growth factor-1; IGFBP-1, insulin-like growth factor binding protein-1; RGD, arginine-glycine-aspartic acid.](ajas-28-1-20f1){#f1-ajas-28-1-20}

![Tissue distribution of the gene expression of IGF-1 and IGFBP-1. RT-PCR was performed on the cDNA from the yak, and the *β-actin* gene was chosen as the positive control. H, heart; Li, liver; S, spleen; Lu, lung; K, kidney; LI, large intestine; SI, small intestine; S, stomach; M, muscle; O, ovary; T, testis; B, brain; IGF-1, insulin-like growth factor-1; IGFBP-1, insulin-like growth factor binding protein-1; RT-PCR, reverse transcriptase-polyerase chain reaction.](ajas-28-1-20f2){#f2-ajas-28-1-20}

![Expression levels of IGF-1 and IGFBP-1 in the livers and kidneys from *B. grunniens* (n = 6) and *B. taurus* (n = 6). Gene expression was normalized to the expression of β-actin. Different letters in the same tissue indicate difference between breeds (p\<0.05). IGF-1, insulin-like growth factor-1; IGFBP-1, insulin-like growth factor binding protein-1.](ajas-28-1-20f3){#f3-ajas-28-1-20}
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